U.S., Sept. 17 -- ClinicalTrials.gov registry received information related to the study (NCT07821931) titled 'Suzetrigine in Tonsillectomy for Opioid-sparing Pain Management' on Sept. 10.
Brief Summary: The goal of this clinical trial is to learn if a non-opioid pain medicine called suzetrigine can lower how much opioid pain medicine adults need after tonsil surgery (tonsillectomy) or a similar throat surgery.
Study Start Date: Nov., 2026
Study Type: INTERVENTIONAL
Condition:
Tonsillectomy
Pharyngoplasty
Suzetrigine
Opioid
Postoperative Pain
Acute Pain
Intervention:
DRUG: Suzetrigine
Suzetrigine is administered at its FDA-approved dose for moderate-to-severe acute pain: a 100 mg oral loading dose followed by 50 mg orally every 12 ho...